A+ | A | A- | Skip to main content |

Sensex

Nifty

USDINR

GBPINR

EURINR

Tuesday, 01 September 2026 12:00 AM EOD	Asian-Paints2568.10	Hind-Unilever1995.00	ITC266.45	Trent2850.20	Larsen-and-Toubro3990.00	M-and-M3242.50	Reliance-Industries1307.35	Tata-Steel183.95	Titan-Company5035.00	SBI1033.40	Bharat-Electron410.95	Kotak-Mah-Bank424.70	Infosys1154.00	Bajaj-Finance1053.10	Sun-PharmaInds1930.45	HDFC-Bank712.05	TCS2366.00	ICICI-Bank1436.80	Power-Grid-Corpn264.85	Maruti-Suzuki12919.00	Axis-Bank1259.95	HCL-Technologies1351.00	NTPC327.00	Bharti-Airtel1872.00	Tech-Mahindra1636.00	Adani-Ports1646.00	UltraTech-Cem11399.00	Bajaj-Finserv1970.00	Interglobe-Aviat5055.50	Eternal327.85
15 mins delay SENSEX 76,944.28 [-12.99]	-8.80 -0.34%	0.00 0.00%	10.20 3.98%	-29.80 -1.03%	-40.00 -0.99%	-78.50 -2.36%	22.35 1.74%	-0.05 -0.03%	-80.80 -1.58%	-26.60 -2.51%	-3.05 -0.74%	6.45 1.54%	27.45 2.44%	-11.60 -1.09%	-25.55 -1.31%	3.05 0.43%	2.00 0.08%	-13.20 -0.91%	0.70 0.27%	-561.00 -4.16%	-23.05 -1.80%	42.00 3.21%	-0.70 -0.21%	42.00 2.30%	10.80 0.66%	11.00 0.67%	-101.00 -0.88%	-48.45 -2.40%	-128.50 -2.48%	0.15 0.05%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Emcure Pharmaceuticals secures reaffirmed CARE ratings, alongside Gennova Biopharmaceuticals stake acquisition

01-Sep-26 17:06Hrs IST

Emcure Pharmaceuticals Ltd. announced reaffirmations from CARE Ratings Limited and CARE Ratings Ltd. regarding several instruments, including Long-term bank facilities totaling Rs 785.00, Long-term/Short-term bank facilities amounting to Rs 1,563.00, and Short-term bank facilities of Rs 52.00, all carrying ratings of CARE AA; Stable and CARE A1+ respectively, with enhancements to the amounts from Rs 557.50 and Rs 1,348.00 previously; additionally, CARE Ratings Limited (CareEdge Ratings) noted potential for a positive rating upgrade if total operating income and PBILDT margins exceed 22%, while a downgrade could occur if net debt to PBILDT rises above 1.50x or PBILDT margins fall below 15%, alongside the withdrawal of ratings for Non-convertible debentures LT as of January 5, 2024, and the completion of the acquisition of a stake in Gennova Biopharmaceuticals Limited for approximately Rs 232 crore in July 2026, alongside a divestment of its mRNA business for roughly Rs 140 crore.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise